Effect of dexmedetomidine on blood loss and patient outcomes in orthognathic surgery
Phase 4
Completed
- Conditions
- orthognathic surgery patientsdexmedetomidine, blood loss, orthognathic surgery
- Registration Number
- TCTR20230818002
- Lead Sponsor
- self support
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1. patient undergoing bimaxillary orthognathic surgery
2. ASA classification 1 or 2
Exclusion Criteria
1. patient with coagulopathy
2. patient with bradycardia, cardiac dysrhythmias
3. known allergy to the study drugs
4. pregnancy and lactation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method blood loss, postoperative hemoglobin, blood transfusion the end of the operation intra-operative estimated blood loss, postoperative hemoglobin, incidence of blood transfusion
- Secondary Outcome Measures
Name Time Method vital signs the end of operation Intra-operative heart rate, mean arterial pressure, and the amount of vasopressure usage,pain score, opioids requirement 24 hours after operation overall pain score, amount of opioid drug usage(intraoperative, postoperative in recovery room and in first 24 hr),operative time, quality of operative visual field, surgeons' satisfaction the end of operation operative time in minutes, Fromme's scale, Likert scale ,hospital stays, side effects the end of operation and 24 hours after operation episode of bradycardia, hypotension, arrhythmia and nausea/vomiting